You are viewing a preview of...

Monoclonal Antibody Fragments for Targeting Therapeutics to Growth Plate Cartilage

Creation of human monoclonal antibody fragments that bind to matrilin-3, a protein specifically expressed in cartilage tissue.

Background

A child’s growth is dependent on the proper functioning of the growth plate, a specialized cartilage structure located at the ends of long bones and within the vertebrae. The primary function of the growth plate is to generate new cartilage, which is then converted into bone tissue and results in the lengthening of bones. Failure of the growth plate to function properly can result in short stature or sometimes a skeletal dysplasia, such as achondroplasia, in which the bones are not just short but also malformed. Current treatments for severe short stature and skeletal growth disorders are limited. Recombinant human growth hormone (GH) is typically used, but the results are often less than optimal and growth hormone has potential

Log in or create a free account to continue reading